Compare Ascendis Pharma A/S (ASND) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Eli Lilly And Co — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Eli Lilly And Co trades at $1,214.84 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 64.8× Ascendis Pharma A/S's market cap, and Eli Lilly And Co pays a 0.57% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | LLY | |
|---|---|---|
Market Cap | $16.67B | $1.08T |
Sector | Health | Health |
52-Week High | $277.18 | $1.24K |
52-Week Low | $189.74 | $639.43 |
Enterprise Value | $17.04B | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
